Swine Respiratory Disease is a form of infection which is originated from pigs. Some of its symptoms are fever, sore throat, fever, body aches and many more which are caused due to?infection?agents such as mycoplasma hyopneumoniae and bordetella bronchiseptica and viral agents as respiratory syndrome (PRRS) virus. Combination of these agents can increase the severity and even cause death of a person.
This report aims to provide a comprehensive presentation of the global market for Swine Respiratory Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Respiratory Diseases Treatment. This report contains market size and forecasts of Swine Respiratory Diseases Treatment in global, including the following market information:
Global Swine Respiratory Diseases Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Swine Respiratory Diseases Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
By Causative Agent Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Swine Respiratory Diseases Treatment include Zoetis, Virbac, Eli Lilly(Elanco), Merck Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Norbrook, Thermo Fisher Scientific Inc and Vetoquinol, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Swine Respiratory Diseases Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Swine Respiratory Diseases Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Swine Respiratory Diseases Treatment Market Segment Percentages, by Type, 2022 (%)
By Causative Agent
Mycoplasma
Bacteria
Virus
Others
By Treatment Type
Vaccines
Drugs
By Administration
Parenteral
Oral
Global Swine Respiratory Diseases Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Swine Respiratory Diseases Treatment Market Segment Percentages, by Application, 2022 (%)
Veterinary Hospitals
Veterinary Clinics
Pharmacies
Others
Global Swine Respiratory Diseases Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Swine Respiratory Diseases Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Swine Respiratory Diseases Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Swine Respiratory Diseases Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Virbac
Eli Lilly(Elanco)
Merck Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Norbrook
Thermo Fisher Scientific Inc
Vetoquinol
Bimeda holdings PLC
Huvepharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Swine Respiratory Diseases Treatment, market overview.
Chapter 2: Global Swine Respiratory Diseases Treatment market size in revenue.
Chapter 3: Detailed analysis of Swine Respiratory Diseases Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Swine Respiratory Diseases Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Swine Respiratory Diseases Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Swine Respiratory Diseases Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Swine Respiratory Diseases Treatment Overall Market Size
2.1 Global Swine Respiratory Diseases Treatment Market Size: 2022 VS 2029
2.2 Global Swine Respiratory Diseases Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Swine Respiratory Diseases Treatment Players in Global Market
3.2 Top Global Swine Respiratory Diseases Treatment Companies Ranked by Revenue
3.3 Global Swine Respiratory Diseases Treatment Revenue by Companies
3.4 Top 3 and Top 5 Swine Respiratory Diseases Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Swine Respiratory Diseases Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Swine Respiratory Diseases Treatment Players in Global Market
3.6.1 List of Global Tier 1 Swine Respiratory Diseases Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Swine Respiratory Diseases Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Swine Respiratory Diseases Treatment Market Size Markets, 2022 & 2029
4.1.2 Mycoplasma
4.1.3 Bacteria
4.1.4 Virus
4.1.5 Others
4.2 By Type - Global Swine Respiratory Diseases Treatment Revenue & Forecasts
4.2.1 By Type - Global Swine Respiratory Diseases Treatment Revenue, 2018-2023
4.2.2 By Type - Global Swine Respiratory Diseases Treatment Revenue, 2024-2029
4.2.3 By Type - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Swine Respiratory Diseases Treatment Market Size, 2022 & 2029
5.1.2 Veterinary Hospitals
5.1.3 Veterinary Clinics
5.1.4 Pharmacies
5.1.5 Others
5.2 By Application - Global Swine Respiratory Diseases Treatment Revenue & Forecasts
5.2.1 By Application - Global Swine Respiratory Diseases Treatment Revenue, 2018-2023
5.2.2 By Application - Global Swine Respiratory Diseases Treatment Revenue, 2024-2029
5.2.3 By Application - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Swine Respiratory Diseases Treatment Market Size, 2022 & 2029
6.2 By Region - Global Swine Respiratory Diseases Treatment Revenue & Forecasts
6.2.1 By Region - Global Swine Respiratory Diseases Treatment Revenue, 2018-2023
6.2.2 By Region - Global Swine Respiratory Diseases Treatment Revenue, 2024-2029
6.2.3 By Region - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Swine Respiratory Diseases Treatment Revenue, 2018-2029
6.3.2 US Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.3.3 Canada Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.3.4 Mexico Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Swine Respiratory Diseases Treatment Revenue, 2018-2029
6.4.2 Germany Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.4.3 France Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.4.4 U.K. Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.4.5 Italy Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.4.6 Russia Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.4.8 Benelux Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Swine Respiratory Diseases Treatment Revenue, 2018-2029
6.5.2 China Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.5.3 Japan Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.5.4 South Korea Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.5.6 India Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Swine Respiratory Diseases Treatment Revenue, 2018-2029
6.6.2 Brazil Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.6.3 Argentina Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Swine Respiratory Diseases Treatment Revenue, 2018-2029
6.7.2 Turkey Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.7.3 Israel Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Swine Respiratory Diseases Treatment Market Size, 2018-2029
6.7.5 UAE Swine Respiratory Diseases Treatment Market Size, 2018-2029
7 Swine Respiratory Diseases Treatment Companies Profiles
7.1 Zoetis
7.1.1 Zoetis Company Summary
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Swine Respiratory Diseases Treatment Major Product Offerings
7.1.4 Zoetis Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.1.5 Zoetis Key News & Latest Developments
7.2 Virbac
7.2.1 Virbac Company Summary
7.2.2 Virbac Business Overview
7.2.3 Virbac Swine Respiratory Diseases Treatment Major Product Offerings
7.2.4 Virbac Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.2.5 Virbac Key News & Latest Developments
7.3 Eli Lilly(Elanco)
7.3.1 Eli Lilly(Elanco) Company Summary
7.3.2 Eli Lilly(Elanco) Business Overview
7.3.3 Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Major Product Offerings
7.3.4 Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly(Elanco) Key News & Latest Developments
7.4 Merck Animal Health
7.4.1 Merck Animal Health Company Summary
7.4.2 Merck Animal Health Business Overview
7.4.3 Merck Animal Health Swine Respiratory Diseases Treatment Major Product Offerings
7.4.4 Merck Animal Health Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.4.5 Merck Animal Health Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Swine Respiratory Diseases Treatment Major Product Offerings
7.5.4 Boehringer Ingelheim Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Ceva Sante Animale
7.6.1 Ceva Sante Animale Company Summary
7.6.2 Ceva Sante Animale Business Overview
7.6.3 Ceva Sante Animale Swine Respiratory Diseases Treatment Major Product Offerings
7.6.4 Ceva Sante Animale Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.6.5 Ceva Sante Animale Key News & Latest Developments
7.7 Norbrook
7.7.1 Norbrook Company Summary
7.7.2 Norbrook Business Overview
7.7.3 Norbrook Swine Respiratory Diseases Treatment Major Product Offerings
7.7.4 Norbrook Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.7.5 Norbrook Key News & Latest Developments
7.8 Thermo Fisher Scientific Inc
7.8.1 Thermo Fisher Scientific Inc Company Summary
7.8.2 Thermo Fisher Scientific Inc Business Overview
7.8.3 Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Major Product Offerings
7.8.4 Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.8.5 Thermo Fisher Scientific Inc Key News & Latest Developments
7.9 Vetoquinol
7.9.1 Vetoquinol Company Summary
7.9.2 Vetoquinol Business Overview
7.9.3 Vetoquinol Swine Respiratory Diseases Treatment Major Product Offerings
7.9.4 Vetoquinol Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.9.5 Vetoquinol Key News & Latest Developments
7.10 Bimeda holdings PLC
7.10.1 Bimeda holdings PLC Company Summary
7.10.2 Bimeda holdings PLC Business Overview
7.10.3 Bimeda holdings PLC Swine Respiratory Diseases Treatment Major Product Offerings
7.10.4 Bimeda holdings PLC Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.10.5 Bimeda holdings PLC Key News & Latest Developments
7.11 Huvepharma
7.11.1 Huvepharma Company Summary
7.11.2 Huvepharma Business Overview
7.11.3 Huvepharma Swine Respiratory Diseases Treatment Major Product Offerings
7.11.4 Huvepharma Swine Respiratory Diseases Treatment Revenue in Global Market (2018-2023)
7.11.5 Huvepharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Swine Respiratory Diseases Treatment Market Opportunities & Trends in Global Market
Table 2. Swine Respiratory Diseases Treatment Market Drivers in Global Market
Table 3. Swine Respiratory Diseases Treatment Market Restraints in Global Market
Table 4. Key Players of Swine Respiratory Diseases Treatment in Global Market
Table 5. Top Swine Respiratory Diseases Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Swine Respiratory Diseases Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Swine Respiratory Diseases Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Swine Respiratory Diseases Treatment Product Type
Table 9. List of Global Tier 1 Swine Respiratory Diseases Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Swine Respiratory Diseases Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Swine Respiratory Diseases Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Swine Respiratory Diseases Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Swine Respiratory Diseases Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Swine Respiratory Diseases Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Swine Respiratory Diseases Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Swine Respiratory Diseases Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Zoetis Company Summary
Table 31. Zoetis Swine Respiratory Diseases Treatment Product Offerings
Table 32. Zoetis Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Zoetis Key News & Latest Developments
Table 34. Virbac Company Summary
Table 35. Virbac Swine Respiratory Diseases Treatment Product Offerings
Table 36. Virbac Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Virbac Key News & Latest Developments
Table 38. Eli Lilly(Elanco) Company Summary
Table 39. Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Product Offerings
Table 40. Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly(Elanco) Key News & Latest Developments
Table 42. Merck Animal Health Company Summary
Table 43. Merck Animal Health Swine Respiratory Diseases Treatment Product Offerings
Table 44. Merck Animal Health Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Animal Health Key News & Latest Developments
Table 46. Boehringer Ingelheim Company Summary
Table 47. Boehringer Ingelheim Swine Respiratory Diseases Treatment Product Offerings
Table 48. Boehringer Ingelheim Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Boehringer Ingelheim Key News & Latest Developments
Table 50. Ceva Sante Animale Company Summary
Table 51. Ceva Sante Animale Swine Respiratory Diseases Treatment Product Offerings
Table 52. Ceva Sante Animale Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Ceva Sante Animale Key News & Latest Developments
Table 54. Norbrook Company Summary
Table 55. Norbrook Swine Respiratory Diseases Treatment Product Offerings
Table 56. Norbrook Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Norbrook Key News & Latest Developments
Table 58. Thermo Fisher Scientific Inc Company Summary
Table 59. Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Product Offerings
Table 60. Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Thermo Fisher Scientific Inc Key News & Latest Developments
Table 62. Vetoquinol Company Summary
Table 63. Vetoquinol Swine Respiratory Diseases Treatment Product Offerings
Table 64. Vetoquinol Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Vetoquinol Key News & Latest Developments
Table 66. Bimeda holdings PLC Company Summary
Table 67. Bimeda holdings PLC Swine Respiratory Diseases Treatment Product Offerings
Table 68. Bimeda holdings PLC Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Bimeda holdings PLC Key News & Latest Developments
Table 70. Huvepharma Company Summary
Table 71. Huvepharma Swine Respiratory Diseases Treatment Product Offerings
Table 72. Huvepharma Swine Respiratory Diseases Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Huvepharma Key News & Latest Developments
List of Figures
Figure 1. Swine Respiratory Diseases Treatment Segment by Type in 2022
Figure 2. Swine Respiratory Diseases Treatment Segment by Application in 2022
Figure 3. Global Swine Respiratory Diseases Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Swine Respiratory Diseases Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Swine Respiratory Diseases Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Swine Respiratory Diseases Treatment Revenue in 2022
Figure 8. By Type - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
Figure 16. US Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
Figure 28. China Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Swine Respiratory Diseases Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Zoetis Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Virbac Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Animal Health Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Boehringer Ingelheim Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Ceva Sante Animale Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Norbrook Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Vetoquinol Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bimeda holdings PLC Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Huvepharma Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
